Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-25-057905
Filing Date
2025-06-26
Accepted
2025-06-25 17:31:53
Documents
25
Period of Report
2025-06-25

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT ea0246830-pre14a_180life.htm   iXBRL PRE 14A 1390419
2 GRAPHIC image_001.jpg GRAPHIC 13322
3 GRAPHIC image_002.jpg GRAPHIC 72241
4 GRAPHIC image_003.jpg GRAPHIC 75983
5 GRAPHIC image_004.jpg GRAPHIC 10079
6 GRAPHIC image_005.jpg GRAPHIC 1987
7 GRAPHIC image_006.jpg GRAPHIC 1562
8 GRAPHIC image_007.jpg GRAPHIC 1397
9 GRAPHIC image_008.jpg GRAPHIC 2142
  Complete submission text file 0001213900-25-057905.txt   2817997

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE atnf-20250625.xsd EX-101.SCH 16154
11 XBRL DEFINITION FILE atnf-20250625_def.xml EX-101.DEF 13093
12 XBRL LABEL FILE atnf-20250625_lab.xml EX-101.LAB 50713
13 XBRL PRESENTATION FILE atnf-20250625_pre.xml EX-101.PRE 15839
27 EXTRACTED XBRL INSTANCE DOCUMENT ea0246830-pre14a_180life_htm.xml XML 161832
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38105 | Film No.: 251074599
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)